Approval · Notice of Compliance 28186 · 2022
CONCERTA: Notice of Compliance 28186
Issued May 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28186
- Date
- May 16, 2022
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph and update the Product Monograph to 2020 template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONCERTA | Not yet assigned | — |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 18 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 27 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 36 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 54 MG per TAB